Success in Rare Disease: Patient Involvement Matters!

This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations for the…


Happy Anniversary to Us!

I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and expectations: the smart…


Hybrid Work Strategies: 3 Tips to Transform Engagement

In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation, accelerated…


What’s the Latest?

There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might…


Gen Z Advice for Seasoned Boomers

“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain selective…


The Truth about Teams

When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop and what actually occurs are…


Running the Biopharma Marathon

When I moved to Boston over thirty years ago, I had never even heard of the Boston Marathon. I grew up in the Midwest and moved to…


zebra-pattern-background

Rare Diseases: Shaping Biopharma’s Future from the Past

We just completed Rare Disease month. With that in mind, Sue has asked me to step in for today’s e-conversation, as this topic is very much a part…


Patient Advocacy – Delivering on Patient Centricity in Drug Development

Historically, biopharma companies developed drugs for patients with an illness — but the illness was the primary focus. In recent years, much has…


two arrows heading towards the same target the to moving forward in unison toward goal

Beyond the One-Hit Wonder

Innovation in our industry is extraordinary on so many levels. The science is unparalleled, the collective intellect is exceptional, and the passion…